全文获取类型
收费全文 | 9236篇 |
免费 | 530篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 124篇 |
儿科学 | 177篇 |
妇产科学 | 157篇 |
基础医学 | 1133篇 |
口腔科学 | 904篇 |
临床医学 | 712篇 |
内科学 | 2063篇 |
皮肤病学 | 215篇 |
神经病学 | 650篇 |
特种医学 | 342篇 |
外科学 | 943篇 |
综合类 | 50篇 |
一般理论 | 4篇 |
预防医学 | 1015篇 |
眼科学 | 167篇 |
药学 | 707篇 |
中国医学 | 98篇 |
肿瘤学 | 360篇 |
出版年
2023年 | 85篇 |
2022年 | 228篇 |
2021年 | 345篇 |
2020年 | 249篇 |
2019年 | 286篇 |
2018年 | 358篇 |
2017年 | 231篇 |
2016年 | 259篇 |
2015年 | 326篇 |
2014年 | 454篇 |
2013年 | 484篇 |
2012年 | 677篇 |
2011年 | 826篇 |
2010年 | 395篇 |
2009年 | 339篇 |
2008年 | 548篇 |
2007年 | 575篇 |
2006年 | 394篇 |
2005年 | 403篇 |
2004年 | 316篇 |
2003年 | 296篇 |
2002年 | 251篇 |
2001年 | 167篇 |
2000年 | 153篇 |
1999年 | 127篇 |
1998年 | 60篇 |
1997年 | 76篇 |
1996年 | 65篇 |
1995年 | 35篇 |
1994年 | 31篇 |
1993年 | 33篇 |
1992年 | 45篇 |
1991年 | 73篇 |
1990年 | 53篇 |
1989年 | 58篇 |
1988年 | 52篇 |
1987年 | 49篇 |
1986年 | 48篇 |
1985年 | 52篇 |
1984年 | 37篇 |
1983年 | 40篇 |
1982年 | 23篇 |
1981年 | 23篇 |
1980年 | 22篇 |
1979年 | 18篇 |
1978年 | 16篇 |
1975年 | 13篇 |
1973年 | 14篇 |
1970年 | 14篇 |
1966年 | 13篇 |
排序方式: 共有9821条查询结果,搜索用时 15 毫秒
11.
The role of growth factors and cytokines in the impaired healing of chronic leg ulcers remains uncertain. The aim of this study was to determine whether changes in the amount and location of cytokines and growth factors may be associated with impaired healing in chronic leg ulcers. Biopsies from leg ulcers of 21 patients and from normal skin of nine healthy volunteers were examined immunohistochemically for selected growth factors and cytokines. Greater staining intensity was found in keratinocytes at the edges of ulcers compared to normal skin, or skin adjacent to the ulcers. Staining at the ulcer edge was more intense in nonhealing ulcers for only vascular endothelial growth factor and platelet-derived growth factor, whereas staining in the adjacent skin was more intense for all factors in the nonhealing phase. For all factors staining was cytoplasmic, suggesting production in these areas. This study shows up-regulation of the production of cytokines and growth factors in keratinocytes of chronic leg ulcers that is greater when the ulcers are nonhealing. 相似文献
12.
M. S. Lima F. Kallfelz L. Krook P. W. Nathanielsz 《Calcified tissue international》1993,52(4):283-290
Summary The objective of this study was to evaluate the effects of a long-term, low-calcium diet on fetal calcium metabolism and fetal
skeleton skeleton development in ewes. Eleven pregnant sheep were assigned to two groups, fed either a diet low in calcium
(0.26% total dry matter) or normal in calcium (0.8% total dry matter) for 2 months, starting at 60 days gestational age. The
ewes fed the low calcium diet showed lower plasma levels of calcium and higher plasma levels of hydroxyproline, parathyroid
hormone, and 1,25 (OH)2D compared with the ewes fed the normal calcium diet. There were no differences in these variables between the two groups
of fetuses. These observations suggest that the plasma components of calcium homeostasis measured in the fetal lamb in the
present study are independent of the ewe and are not significantly affected by the presence of lowere maternal calcium for
many weeks during pregnancy. Despite the ability of the fetus of the ewe on the low calcium diet to maintain relatively normal
circulating plasma components of calcium homeostasis, long-term maternal hypocalcemia delayed fetal skeletal ossification
as shown by histological examination of the fetal humerus. The fetal humerus from low calcium-fed ewes showed a lower proportion
of bone versus cartilage (45.6±5.9 versus 57.4±4.6%, mean ±SD) lower ash content (15.4±1.5 versus 17.4±1.0%), and lower specific
gravity (1.19±0.2 versus 1.22±0.02) (P<0.05) than the humerus from fetuses of normal calcium-fed ewes. This study shows that the long-term calcium intake of the
ewe does affect fetal skeletal development, despite a lack of observable effects on fetal plasma concentrations of calcium
or known calcium regulating hormones such as 1,25(OH)2D or parathyroid hormone. 相似文献
13.
L. Lima V. Arce M. J. Diaz J. A. F. Tresguerres J. Devesa 《Clinical endocrinology》1991,35(2):129-135
OBJECTIVE: The aim of this study was to investigate the effect of a single dose of clonidine on the pattern of GH release in response to a 10-hour continuous GRF infusion in normal man. DESIGN: Plasma GH was analysed in samples withdrawn at 20-minute intervals, from 0900 to 1900 h, according to the following protocols: in a control study, a placebo was given at 1000 h; in other experiments, clonidine (300 micrograms, orally) was given at 1000 h, alone or together with a continuous intravenous infusion of GRF 1-29 (0.3 micrograms/kg/h) starting at this time. In another experiment, the continuous infusion of GRF 1-29 was preceded by placebo administration at 1000 h. PATIENTS: Eight normal volunteers (four women and four men), aged 19-24 years were studied. MEASUREMENTS: Plasma GH levels were measured by RIA. Analysis of the pattern of GH secretion was performed using cluster analysis. RESULTS: Clonidine induced a slight but significant increase in plasma GH values, peaking 60 to 120 minutes later; however, no significant changes were observed in indices of total and pulsatile GH release for the whole sampling period in this study. Continuous GRF administration led to increased episodic GH secretion, by augmenting GH peak amplitude, although peak frequency was not modified. An increase in interpulse GH values was also observed during GRF infusion. Pretreatment with clonidine clearly changed the pattern of GH release during GRF infusion: the amount of GH secreted was significantly higher, the number of GH peaks significantly increased, and almost all the GH was secreted within them. CONCLUSIONS: These data concord with our previous demonstration that clonidine disrupts the hypothalamic-somatotroph rhythm by inhibiting the hypothalamic release of somatostatin. Given that clonidine pretreatment induced a more physiological episodic pattern of GRF-induced GH release, the possibility of combining clonidine and GRF therapy for short stature in children is envisaged. 相似文献
14.
15.
16.
Do weekly and fast-rotating shiftwork schedules differentially affect duration and quality of sleep?
F. M. Fischer Antonio Castro Bruni Adelaide Berwerth Claudia Roberta Castro Moreno Rosaneli Lima Fernandez Claudia Riviello 《International archives of occupational and environmental health》1997,69(5):354-360
Characteristics of shiftwork schedules can have distinct impacts on workers’ sleep. This report presents comparisons of the
effects of two different shiftwork schedules on duration and quality of the main sleep episodes in comparable worker populations
at two different petrochemical plants. No significant differences were found for sleep duration in comparing the two plants.
However, within each plant’s shift cycles, morning and night shifts showed shorter sleep durations than all other workdays
and days off. Quality of sleep was perceived as lowest for night shifts of both plant schedules, and of lesser quality for
weekly than for fast-rotating shifts. These results support recommendations for reducing the number of consecutive nights
of shiftwork. However, before recommending any optimal shift schedule, interactions of sleep duration and quality with shift
schedules need much further evaluation.
Received: 18 December 1995/Accepted: 18 July 1996 相似文献
17.
18.
Marcos Barbosa-Ferreira Maria Lúcia Zaidan Dagli Paulo César Maiorka Silvana Lima Górniak 《Food and chemical toxicology》2005,43(4):497-503
Senna occidentalis (So) is a weed that grows in pastures along fences and in fields cultivated with cereals such as corn and soybean, and many reports have been showing intoxication with this plant in different animal species. It is also used in many medicinal purposes. The objective of the present study was to better evaluate the toxic effects of prolonged administration of So seeds to rats. Forty male Wistar rats were divided into four groups of 10 animals each, three of them respectively fed rations containing 1%, 2% and 4% So seeds, and the last one (control) fed commercial ration for a period of 2 weeks. Fourteen rats were also used in a pair-feeding (PF) experiment. The rats of the experimental groups showed lethargy, weakness, recumbency, depression and emaciation. Two rats of the 4% group and two of the PF group died during the experiment. Histopathological study showed fiber degenerations in the skeletal (Tibial, pectoral and diaphragm) and cardiac muscles. In the liver parenchyma, was observed vacuolar degeneration and, in the kidney, mild nefrosis in the proximal convoluted tubules. All of these alterations occurred in a dose-dependent fashion. Moderate to severe degeneration and spongiosis in the central nervous system, especially in cerebellum. Electron microscopy revealed mitochondrial lesions in all analyzed tissues. 相似文献
19.
20.
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 总被引:1,自引:0,他引:1
Collins CE Benson MJ Burnham WR Rampton DS 《Alimentary pharmacology & therapeutics》1996,10(3):315-320
BACKGROUND: Inflammatory bowel disease is associated with increased mucosal release of eicosanoids. Among these, thromboxane A2 has been proposed as a possible inflammatory mediator; its suppression may be a useful therapeutic option. METHODS: Using a tissue incubation technique, we compared release of immunoreactive thromboxane B2 by colonic biopsies from patients with ulcerative colitis, Crohn's disease and controls, and assessed the inhibitory effect of picotamide, a thromboxane synthesis inhibitor-receptor antagonist, which has been widely used in Italy for management of ischaemic heart and cerebrovascular disease. RESULTS: Increased amounts of thromboxane B2 were released from biopsies from patients with active ulcerative colitis (median 238 pg/20 min/mg wet weight (interquartile range 147- 325), n = 12) and active Crohn's disease (252 (174-450), 6) compared with those from patients with quiescent ulcerative colitis (95 (61- 140), 12) or Crohn's disease (105 (57-201), 13), or controls (136 (64- 206), 8). Incubation with picotamide at concentrations between 100 microM and 1 mM reduced thromboxane B2 release (IC50 890 microM). CONCLUSION: Since increased thromboxane A2 production may have pathogenetic importance, thromboxane synthesis inhibitor-receptor antagonists such as picotamide merit therapeutic trial in the management of inflammatory bowel disease. 相似文献